Catalyst Historical Balance Sheet

CPRX Stock

USD 23.88 0.08 0.33%

Trend analysis of Catalyst Pharmaceuticals balance sheet accounts such as Total Stockholder Equity of 468.4 M, Cash of 166.2 M or Other Assets of 1.09 provides information on Catalyst Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Catalyst Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Catalyst Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Catalyst Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Catalyst Pharmaceuticals is a good buy for the upcoming year.

Catalyst Pharmaceuticals Inventory

18.89 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Catalyst Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.

About Catalyst Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Catalyst Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Catalyst Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Catalyst Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Catalyst currently owns. An asset can also be divided into two categories, current and non-current.

Catalyst Pharmaceuticals Balance Sheet Chart

At this time, Catalyst Pharmaceuticals' Total Current Liabilities is fairly stable compared to the past year. Property Plant And Equipment Net is likely to rise to about 4.5 M in 2025, despite the fact that Net Debt is likely to grow to (114.6 M).

Total Assets Total Stockholder Equity Other Assets Cash And Short Term Investments Non Current Liabilities Other

Add Fundamental

Total Assets

Total assets refers to the total amount of Catalyst Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Catalyst Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Catalyst Pharmaceuticals balance sheet. This account contains Catalyst Pharmaceuticals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Catalyst Pharmaceuticals fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from Catalyst Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Catalyst Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Catalyst Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.At this time, Catalyst Pharmaceuticals' Total Current Liabilities is fairly stable compared to the past year. Property Plant And Equipment Net is likely to rise to about 4.5 M in 2025, despite the fact that Net Debt is likely to grow to (114.6 M).

	2022	2023	2024	2025 (projected)
Total Stockholder Equity	300.4M	387.9M	446.1M	468.4M
Total Assets	375.6M	470.1M	540.6M	567.7M

Total Stockholder Equity Total Assets

Catalyst Pharmaceuticals balance sheet Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Non Current Assets Total	Common Stock Total Equity	Property Plant And Equipment Gross	Common Stock	Property Plant Equipment	Non Currrent Assets Other	Other Current Assets	Net Receivables	Other Liab	Non Current Liabilities Total	Net Tangible Assets
Total Assets		1.0	-0.72	0.81	0.18	0.77	0.78	0.84	0.99	0.92	0.99	0.99	0.93	0.83	0.93	0.93	0.52	0.95	0.54	0.43	-0.86	0.95	0.89	0.85	0.72	0.98
Total Stockholder Equity	1.0		-0.71	0.81	0.19	0.77	0.78	0.85	0.98	0.92	0.99	0.99	0.93	0.83	0.93	0.93	0.52	0.95	0.55	0.44	-0.86	0.95	0.89	0.85	0.71	0.98
Net Debt	-0.72	-0.71		-0.99	-0.63	-0.98	-0.67	-0.71	-0.72	-0.92	-0.66	-0.68	-0.76	-0.51	-0.43	-0.41	-0.62	-0.71	-0.62	-0.54	0.34	-0.57	-0.34	-0.81	-0.88	-0.82
Cash	0.81	0.81	-0.99		0.57	0.99	0.73	0.77	0.81	0.97	0.76	0.77	0.83	0.6	0.55	0.54	0.61	0.8	0.61	0.55	-0.45	0.67	0.47	0.86	0.89	0.89
Other Assets	0.18	0.19	-0.63	0.57		0.59	0.3	0.28	0.12	0.45	0.13	0.1	0.21	0.07	-0.08	-0.1	0.36	0.15	0.35	0.47	0.17	0.17	-0.21	0.47	0.42	0.35
Cash And Short Term Investments	0.77	0.77	-0.98	0.99	0.59		0.77	0.8	0.77	0.96	0.72	0.73	0.81	0.52	0.51	0.49	0.67	0.77	0.67	0.58	-0.42	0.63	0.43	0.82	0.87	0.87
Common Stock Shares Outstanding	0.78	0.78	-0.67	0.73	0.3	0.77		0.98	0.74	0.82	0.71	0.75	0.71	0.31	0.69	0.62	0.86	0.71	0.87	0.44	-0.67	0.75	0.66	0.76	0.51	0.82
Other Stockholder Equity	0.84	0.85	-0.71	0.77	0.28	0.8	0.98		0.8	0.87	0.78	0.81	0.77	0.41	0.76	0.7	0.83	0.78	0.84	0.45	-0.72	0.82	0.72	0.79	0.55	0.88
Total Liab	0.99	0.98	-0.72	0.81	0.12	0.77	0.74	0.8		0.91	0.98	1.0	0.92	0.85	0.92	0.92	0.47	0.94	0.49	0.37	-0.84	0.92	0.88	0.84	0.76	0.96
Total Current Assets	0.92	0.92	-0.92	0.97	0.45	0.96	0.82	0.87	0.91		0.88	0.89	0.91	0.68	0.73	0.71	0.65	0.9	0.66	0.55	-0.64	0.81	0.66	0.89	0.85	0.97
Other Current Liab	0.99	0.99	-0.66	0.76	0.13	0.72	0.71	0.78	0.98	0.88		0.98	0.91	0.88	0.93	0.95	0.43	0.94	0.46	0.4	-0.87	0.94	0.9	0.8	0.72	0.95
Total Current Liabilities	0.99	0.99	-0.68	0.77	0.1	0.73	0.75	0.81	1.0	0.89	0.98		0.91	0.84	0.95	0.94	0.47	0.94	0.5	0.37	-0.87	0.95	0.91	0.85	0.7	0.95
Property Plant And Equipment Net	0.93	0.93	-0.76	0.83	0.21	0.81	0.71	0.77	0.92	0.91	0.91	0.91		0.79	0.8	0.81	0.48	0.99	0.49	0.69	-0.73	0.81	0.77	0.83	0.72	0.93
Retained Earnings	0.83	0.83	-0.51	0.6	0.07	0.52	0.31	0.41	0.85	0.68	0.88	0.84	0.79		0.79	0.85	0.04	0.82	0.07	0.3	-0.71	0.77	0.76	0.64	0.66	0.77
Accounts Payable	0.93	0.93	-0.43	0.55	-0.08	0.51	0.69	0.76	0.92	0.73	0.93	0.95	0.8	0.79		0.99	0.4	0.85	0.43	0.25	-0.95	0.96	0.98	0.74	0.47	0.86
Non Current Assets Total	0.93	0.93	-0.41	0.54	-0.1	0.49	0.62	0.7	0.92	0.71	0.95	0.94	0.81	0.85	0.99		0.32	0.87	0.34	0.26	-0.94	0.94	0.98	0.69	0.49	0.84
Common Stock Total Equity	0.52	0.52	-0.62	0.61	0.36	0.67	0.86	0.83	0.47	0.65	0.43	0.47	0.48	0.04	0.4	0.32		0.46	1.0	0.37	-0.39	0.48	0.36	0.56	0.36	0.6
Property Plant And Equipment Gross	0.95	0.95	-0.71	0.8	0.15	0.77	0.71	0.78	0.94	0.9	0.94	0.94	0.99	0.82	0.85	0.87	0.46		0.48	0.63	-0.79	0.86	0.83	0.82	0.69	0.94
Common Stock	0.54	0.55	-0.62	0.61	0.35	0.67	0.87	0.84	0.49	0.66	0.46	0.5	0.49	0.07	0.43	0.34	1.0	0.48		0.37	-0.41	0.51	0.39	0.58	0.37	0.62
Property Plant Equipment	0.43	0.44	-0.54	0.55	0.47	0.58	0.44	0.45	0.37	0.55	0.4	0.37	0.69	0.3	0.25	0.26	0.37	0.63	0.37		-0.22	0.32	0.21	0.52	0.3	0.53
Non Currrent Assets Other	-0.86	-0.86	0.34	-0.45	0.17	-0.42	-0.67	-0.72	-0.84	-0.64	-0.87	-0.87	-0.73	-0.71	-0.95	-0.94	-0.39	-0.79	-0.41	-0.22		-0.89	-0.96	-0.63	-0.4	-0.77
Other Current Assets	0.95	0.95	-0.57	0.67	0.17	0.63	0.75	0.82	0.92	0.81	0.94	0.95	0.81	0.77	0.96	0.94	0.48	0.86	0.51	0.32	-0.89		0.91	0.85	0.54	0.92
Net Receivables	0.89	0.89	-0.34	0.47	-0.21	0.43	0.66	0.72	0.88	0.66	0.9	0.91	0.77	0.76	0.98	0.98	0.36	0.83	0.39	0.21	-0.96	0.91		0.63	0.4	0.8
Other Liab	0.85	0.85	-0.81	0.86	0.47	0.82	0.76	0.79	0.84	0.89	0.8	0.85	0.83	0.64	0.74	0.69	0.56	0.82	0.58	0.52	-0.63	0.85	0.63		0.67	0.9
Non Current Liabilities Total	0.72	0.71	-0.88	0.89	0.42	0.87	0.51	0.55	0.76	0.85	0.72	0.7	0.72	0.66	0.47	0.49	0.36	0.69	0.37	0.3	-0.4	0.54	0.4	0.67		0.76
Net Tangible Assets	0.98	0.98	-0.82	0.89	0.35	0.87	0.82	0.88	0.96	0.97	0.95	0.95	0.93	0.77	0.86	0.84	0.6	0.94	0.62	0.53	-0.77	0.92	0.8	0.9	0.76

Click cells to compare fundamentals

Catalyst Pharmaceuticals Account Relationship Matchups

Catalyst Pharmaceuticals balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	192.4M	237.8M	375.6M	470.1M	540.6M	567.7M
Total Stockholder Equity	169.6M	206.8M	300.4M	387.9M	446.1M	468.4M
Net Debt	(130.2M)	(167.6M)	(294.5M)	(134.1M)	(120.7M)	(114.6M)
Cash	130.2M	171.4M	298.4M	137.6M	158.3M	166.2M
Other Assets	33.0M	23.7M	18.7M	1.0	1.15	1.09
Cash And Short Term Investments	140.3M	191.3M	298.4M	137.6M	158.3M	166.2M
Common Stock Shares Outstanding	106.2M	107.8M	111.4M	113.8M	130.8M	137.4M
Liabilities And Stockholders Equity	192.4M	237.8M	375.6M	470.1M	540.6M	567.7M
Other Stockholder Equity	223.2M	233.2M	250.4M	266.5M	306.5M	321.8M
Total Liab	22.8M	31.0M	75.2M	82.2M	94.6M	99.3M
Total Current Assets	159.2M	210.1M	320.8M	219.3M	252.2M	264.8M
Other Current Liab	18.5M	23.9M	44.6M	60.2M	69.2M	72.7M
Total Current Liabilities	22.8M	27.1M	57.6M	76.1M	87.5M	91.8M
Property Plant And Equipment Net	129.8K	4.0M	3.6M	3.7M	4.3M	4.5M
Retained Earnings	(53.7M)	(26.3M)	49.9M	121.3M	109.1M	114.6M
Accounts Payable	4.3M	2.8M	4.0M	14.8M	17.0M	17.9M
Non Current Assets Total	33.1M	27.7M	54.8M	250.8M	288.4M	302.8M
Common Stock Total Equity	103.4K	103.8K	103K	105K	120.8K	66.6K
Property Plant And Equipment Gross	129.8K	4.0M	3.6M	4.4M	5.1M	5.3M
Accumulated Other Comprehensive Income	31.3K	(148K)	24K	14K	12.6K	13.2K
Common Stock	103.8K	103K	105K	107K	123.1K	69.1K
Property Plant Equipment	210.5K	129.8K	4.0M	847K	974.1K	1.0M
Other Current Assets	8.3M	4.4M	5.2M	12.5M	14.4M	15.1M
Net Receivables	6.0M	6.6M	10.4M	53.5M	61.5M	64.6M
Non Current Liabilities Total	4.3M	3.9M	17.6M	6.2M	7.1M	7.5M
Net Tangible Assets	87.6M	169.6M	206.8M	268.0M	308.1M	323.5M
Retained Earnings Total Equity	(160.6M)	(128.7M)	(26.3M)	49.9M	57.3M	60.2M
Capital Surpluse	211.3M	216.2M	233.2M	250.4M	288.0M	169.1M
Inventory	4.7M	7.9M	6.8M	15.6M	18.0M	18.9M
Net Invested Capital	169.6M	206.8M	300.4M	387.9M	446.1M	468.4M
Net Working Capital	136.5M	183.0M	263.2M	143.3M	164.8M	147.7M
Capital Stock	103.8K	103K	105K	107K	123.1K	114.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Additional Tools for Catalyst Stock Analysis

When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Catalyst Historical Balance Sheet

Catalyst Pharmaceuticals Inventory

18.89 Million

About Catalyst Balance Sheet Analysis

Catalyst Pharmaceuticals Balance Sheet Chart

Total Assets

Total Stockholder Equity

Cash And Short Term Investments

Catalyst Pharmaceuticals balance sheet Correlations

Catalyst Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Catalyst Pharmaceuticals balance sheet Accounts

Also Currently Popular

Additional Tools for Catalyst Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Total Liab
Common Stock	+ 1.0	Common Stock Total Equity
Total Liab	+ 0.99	Total Assets
Other Current Liab	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Total Assets

Cash	- 0.99	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Net Receivables	- 0.96	Non Currrent Assets Other
Non Currrent Assets Other	- 0.95	Accounts Payable
Non Currrent Assets Other	- 0.94	Non Current Assets Total
Total Current Assets	- 0.92	Net Debt